Clinical Trials Directory

Trials / Completed

CompletedNCT06244615

Clinical Trial of a Mouth and Throat Rinse for the Treatment of Acute Sore Throat

A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial of an Antiviral Mouth and Throat Rinse for the Treatment of Acute Sore Throat (Upper Respiratory Tract Infection e.g., Pharyngitis/Laryngitis)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
154 (actual)
Sponsor
Dr. August Wolff GmbH & Co. KG Arzneimittel · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to confirm the efficacy, safety and tolerability of the Mouth and Throat Rinse in adult participants with acute sore throat (upper respiratory tract infection e.g., pharyngitis/laryngitis) compared to placebo.

Conditions

Interventions

TypeNameDescription
DEVICEVerum (WO 6607)Mouth and throat rinse and gargle solution
DEVICEPlacebo (WO 6608)Mouth and throat rinse and gargle solution

Timeline

Start date
2024-03-25
Primary completion
2025-02-17
Completion
2025-02-17
First posted
2024-02-06
Last updated
2025-04-11

Locations

1 site across 1 country: Ukraine

Source: ClinicalTrials.gov record NCT06244615. Inclusion in this directory is not an endorsement.

Clinical Trial of a Mouth and Throat Rinse for the Treatment of Acute Sore Throat (NCT06244615) · Clinical Trials Directory